Moh coleads McKinsey’s medical products operations work globally. He brings more than 15 years of experience to his work with clients in the medical-device, pharmaceutical, and life-science industries on operations issues including product development, supply chain, procurement, manufacturing, and quality and compliance.
Moh helps medical-device and technology clients to develop strategies and pursue operational transformations that spur innovation and unlock sustainable growth.
Examples of his recent engagement experience include the following:
- leading multiple end-to-end operations diagnostics and transformations for leading medical-device companies, including manufacturing and distribution-network optimization and manufacturing, quality, and SKU rationalization
- performing multiple preacquisition due diligences on products, manufacturing, supply chain, and quality for various private-equity and medical-device clients, and developing tactical integration plans to mitigate risks after acquisitions
- leading multiple product-development and design projects focused on emerging technologies and applications
- developing a medical-device launch and integration strategy within the healthcare ecosystem
- developing an infectious disease diagnostic and management network strategy in a highly complex environment
Before joining McKinsey, Moh founded a medical device company that integrated cutting-edge micro and nano technologies to introduce point-of-care molecular diagnostic devices. The company was recognized as one of Canada's top ten life-science companies. He also held a strategic marketing role with a medical-technology company in Singapore. Earlier in his career. Moh was an assembly and maintenance technician for medical-imaging devices.
Published work
“Medtech’s call to action: Meeting the demand surge caused by COVID-19,” McKinsey & Company, September 2020
“COVID-19 exposes a critical shortage of oxygen in developing countries,” McKinsey & Company, August 2020
“COVID-19: Overcoming supply shortages for diagnostic testing,” McKinsey & Company, July 2020
“Rethinking manufacturing and distribution networks in medtech,” McKinsey & Company, December 2019
Past Experience
Biolithic Corporation
Cofounder, chief technology officer
Becton Dickinson and Company
Strategic marketing
University of Alberta Nanofabrication, Alberta Cross Cancer Institute, and DALSA Semiconductor
Research associate
Education
University of Alberta
PhD, nano/micro technologies, molecular diagnostics
MSc, electrical engineering, microelectronics
INSEAD
MBA